VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $444,000 | +11.8% | 2,000 | 0.0% | 0.13% | +15.5% |
| Q1 2015 | $397,000 | +38.8% | 2,000 | 0.0% | 0.12% | +41.5% |
| Q4 2014 | $286,000 | +9.2% | 2,000 | 0.0% | 0.08% | +9.3% |
| Q3 2014 | $262,000 | +4.0% | 2,000 | 0.0% | 0.08% | +1.4% |
| Q2 2014 | $252,000 | +18.3% | 2,000 | -4.8% | 0.07% | +131.2% |
| Q3 2013 | $213,000 | -99.9% | 2,100 | -47.5% | 0.03% | -63.6% |
| Q2 2013 | $172,332,000 | – | 4,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |